Instil Bio, Inc. Depreciation and Amortization
Instil Bio, Inc. (TIL) reported Depreciation and Amortization of $260.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-13
- Instil Bio, Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $248.00K, a 1966.67% increase year-over-year.
- Instil Bio, Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $12.00K, a 97.59% decline year-over-year.
- Instil Bio, Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $12.00K, a 98.38% decline year-over-year.
- Instil Bio, Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $12.00K, a 98.67% decline year-over-year.
- Instil Bio, Inc. depreciation, depletion and amortization for fiscal 2025 was $534.00K, a 85.21% decline from fiscal 2024.
- Instil Bio, Inc. depreciation, depletion and amortization for fiscal 2024 was $3.61M, a 24.10% decline from fiscal 2023.
- Instil Bio, Inc. depreciation, depletion and amortization for fiscal 2023 was $4.76M, a 20.56% decline from fiscal 2022.
- Instil Bio, Inc. depreciation, depletion and amortization for fiscal 2022 was $5.99M, a 117.55% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $260.00K 10-Q · filed 2026-08-13 | $272.00K derived: sum of 3 quarters · filed 2026-08-13 | $284.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-15 | $24.00K derived: sum of 2 quarters · filed 2026-05-15 | $36.00K derived: sum of 3 quarters · filed 2026-05-15 | $48.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $24.00K derived: sum of 2 quarters · filed 2026-03-27 | $36.00K derived: sum of 3 quarters · filed 2026-08-13 | $534.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $24.00K derived: sum of 2 quarters · filed 2026-08-13 | $522.00K 10-Q · filed 2025-11-13 | $1.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $510.00K 10-Q · filed 2026-08-13 | $1.25M derived: sum of 3 quarters · filed 2026-08-13 | $2.15M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $498.00K 10-Q · filed 2026-05-15 | $1.24M derived: sum of 2 quarters · filed 2026-05-15 | $2.14M derived: sum of 3 quarters · filed 2026-05-15 | $3.12M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.64M derived: sum of 2 quarters · filed 2026-03-27 | $2.62M derived: sum of 3 quarters · filed 2026-03-27 | $3.61M 10-K · filed 2026-03-27 |
| 2024-09-30 | $901.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.88M derived: sum of 2 quarters · filed 2025-11-13 | $2.87M 10-Q · filed 2025-11-13 | $3.90M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $975.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.97M 10-Q · filed 2025-08-13 | $3.00M derived: sum of 3 quarters · filed 2025-08-13 | $3.96M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $993.00K 10-Q · filed 2025-05-13 | $2.03M derived: sum of 2 quarters · filed 2025-05-13 | $2.98M derived: sum of 3 quarters · filed 2025-05-13 | $3.97M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.99M derived: sum of 2 quarters · filed 2025-03-04 | $2.98M derived: sum of 3 quarters · filed 2025-03-04 | $4.76M 10-K · filed 2025-03-04 |
| 2023-09-30 | $953.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.94M derived: sum of 2 quarters · filed 2024-11-13 | $3.72M 10-Q · filed 2024-11-13 | $5.82M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $991.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.77M 10-Q · filed 2024-08-13 | $4.87M derived: sum of 3 quarters · filed 2024-08-13 | $6.80M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.78M 10-Q · filed 2024-05-10 | $3.88M derived: sum of 2 quarters · filed 2024-05-10 | $5.81M derived: sum of 3 quarters · filed 2024-05-10 | $6.86M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $4.04M derived: sum of 2 quarters · filed 2024-03-21 | $5.09M derived: sum of 3 quarters · filed 2024-03-21 | $5.99M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.99M derived: sum of 2 quarters · filed 2023-11-13 | $3.89M 10-Q · filed 2023-11-13 | $4.78M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.95M 10-Q · filed 2023-08-14 | $2.84M derived: sum of 3 quarters · filed 2023-08-14 | $3.61M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $899.00K 10-Q · filed 2023-05-11 | $1.79M derived: sum of 2 quarters · filed 2023-05-11 | $2.56M derived: sum of 3 quarters · filed 2023-05-11 | $3.21M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $893.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.66M derived: sum of 2 quarters · filed 2023-03-31 | $2.31M derived: sum of 3 quarters · filed 2023-03-31 | $2.75M 10-K · filed 2023-03-31 |
| 2021-09-30 | $764.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.42M derived: sum of 2 quarters · filed 2022-11-14 | $1.86M 10-Q · filed 2022-11-14 | $2.01M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.09M 10-Q · filed 2022-08-12 | $1.24M derived: sum of 3 quarters · filed 2022-08-12 | $1.31M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $439.00K 10-Q · filed 2022-05-16 | $587.00K derived: sum of 2 quarters · filed 2022-05-16 | $654.00K derived: sum of 3 quarters · filed 2022-05-16 | $688.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $215.00K derived: sum of 2 quarters · filed 2022-03-07 | $249.00K derived: sum of 3 quarters · filed 2022-03-07 | $256.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $101.00K derived: sum of 2 quarters · filed 2021-11-15 | $108.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $41.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |